12:00 AM
Apr 15, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Vascugel: Phase II started

Shire began the single-blind, U.S. Phase II AVF01-SRM003 trial to compare 2 Vascugel sponges implanted at the time of AVF surgery vs. standard of care in about 200 ESRD...

Read the full 125 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >